- $1.18bn
- $1.55bn
- $1.13bn
- 46
- 75
- 99
- 86
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 23.53 | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | -5.64% | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.98 | ||
Price to Tang. Book | 1.03 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 1.04 | ||
EV to EBITDA | 19.12 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 1.12% | ||
Return on Equity | 4.56% | ||
Operating Margin | 5.52% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 888.37 | 1,075.44 | 1,103.56 | 1,133.53 | 1,130.6 | 1,080.06 | 1,084.84 | 2.27% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | -13.27 | +13.27 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
ProAssurance Corporation is a specialty insurer with expertise in medical professional liability, products liability for medical technology and life sciences, legal professional liability, and workers' compensation insurance. The Company's segments include Specialty P&C, Workers' Compensation Insurance, Segregated Portfolio Cell Reinsurance and Corporate. The Specialty Property and Casualty (Specialty P&C) segment is focused on professional liability insurance and medical technology liability insurance. Professional liability insurance is offered to healthcare providers and institutions and, to a lesser extent, to attorneys and their firms. The Workers' Compensation Insurance segment offers workers' compensation products in approximately 19 states in the East, South and Midwest regions of the continental United States. The Segregated Portfolio Cell Reinsurance segment includes the results of SPCs at Inova Re and Eastern Re, the Company's Cayman Islands SPC operations.
Directors
- William Starnes CHM (72)
- Edward Rand PRE (54)
- Dana Hendricks CFO (53)
- Michael Boguski CEX (58)
- Kevin Shook CEX (51)
- Noreen Dishart CHO (57)
- Jeffrey Lisenby EVP (52)
- Thomas Wilson LED (59)
- Fabiola Cobarrubias DRC (54)
- Scott Syphax DRC (52)
- Kedrick Adkins IND (68)
- Bruce Angiolillo IND (68)
- Samuel Di Piazza IND (70)
- Maye Frei IND (50)
- Magnus Gorrie IND (58)
- Ziad Haydar IND (58)
- Frank Spinosa IND (66)
- Katisha Vance IND (46)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- October 20th, 2000
- Public Since
- September 4th, 1991
- No. of Shareholders
- 3,767
- No. of Employees
- 1,036
- Sector
- Insurance
- Industry
- Financials
- Exchange
New York Stock Exchange
- Shares in Issue
- 51,069,793

- Address
- 100 Brookwood Pl, BIRMINGHAM, 35209-6811
- Web
- https://www.proassurance.com/
- Phone
- +1 2058774400
- Contact
- Heather Wietzel
- Auditors
- Ernst & Young LLP
Upcoming Events for PRA
ProAssurance Corp Annual Shareholders Meeting
ProAssurance Corp Annual Shareholders Meeting
Q2 2025 ProAssurance Corp Earnings Release
Similar to PRA
Aegon
New York Stock Exchange
Aflac
New York Stock Exchange
Allstate
New York Stock Exchange
Ambac Financial
New York Stock Exchange
American Financial
New York Stock Exchange
FAQ
As of Today at 22:45 UTC, shares in ProAssurance are trading at $23.10. This share price information is delayed by 15 minutes.
Shares in ProAssurance last closed at $23.10 and the price had moved by +69.23% over the past 365 days. In terms of relative price strength the ProAssurance share price has outperformed the S&P500 Index by +56.21% over the past year.
The overall consensus recommendation for ProAssurance is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreProAssurance does not currently pay a dividend.
ProAssurance does not currently pay a dividend.
ProAssurance does not currently pay a dividend.
To buy shares in ProAssurance you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $23.10, shares in ProAssurance had a market capitalisation of $1.18bn.
Here are the trading details for ProAssurance:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: PRA
Based on an overall assessment of its quality, value and momentum ProAssurance is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in ProAssurance is $20.33. That is 11.99% below the last closing price of $23.10.
Analysts covering ProAssurance currently have a consensus Earnings Per Share (EPS) forecast of $0.94 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like ProAssurance. Over the past six months, its share price has outperformed the S&P500 Index by +62.31%.
As of the last closing price of $23.10, shares in ProAssurance were trading +46.5% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The ProAssurance PE ratio based on its reported earnings over the past 12 months is 23.53. The shares last closed at $23.10.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
ProAssurance's management team is headed by:
- William Starnes - CHM
- Edward Rand - PRE
- Dana Hendricks - CFO
- Michael Boguski - CEX
- Kevin Shook - CEX
- Noreen Dishart - CHO
- Jeffrey Lisenby - EVP
- Thomas Wilson - LED
- Fabiola Cobarrubias - DRC
- Scott Syphax - DRC
- Kedrick Adkins - IND
- Bruce Angiolillo - IND
- Samuel Di Piazza - IND
- Maye Frei - IND
- Magnus Gorrie - IND
- Ziad Haydar - IND
- Frank Spinosa - IND
- Katisha Vance - IND